DV
Dividend Vision

ANIX Stock — Anixa Biosciences Inc

Anixa Biosciences Inc (ANIX)

Updated November 9, 2026.

ANIX is a stock. Total return is -94.0% over the past 42 years.

Anixa Biosciences is a biotechnology company developing therapies and vaccines focused on cancer treatment, including a novel CAR-T cell therapy for ovarian cancer and vaccine candidates targeting breast cancer and other solid tumors. The company does not currently distribute to shareholders. This security appeals to investors seeking exposure to early-stage oncology development with a tolerance for biotechnology risk and no expectation of current income.

ANIX performance

Total return is -94.0% over the past 42 years. Over the past year its total return — price change plus distributions reinvested — is -24.6%. Its deepest 1-year drawdown was 55.0%.

WindowTotal returnCAGR
1M9.0%—
3M-7.6%—
6M5.3%—
YTD1.3%—
1Y-24.6%—
2Y CAGR—-4.10%
3Y CAGR—3.00%
5Y CAGR—-8.50%
10Y CAGR—-5.80%
Since inception 1984-11-05 · 42 years-94.0%-6.50%

ANIX key facts

Asset type
Stock
Asset class
Equity
Inception date
11/05/1984
Distribution frequency
None
Last close
$3.16 (as of 2026-11-09)
Market cap
$109,853,614
Average volume
126,713
Beta
0.476
Payout ratio
0.0%
EPS
-$0.33

How Dividend Vision calculates returns

Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ANIX risks and drawbacks

The deepest 1-year drawdown on record here is 55.0%.

Who may consider ANIX — and who may not

It is a weaker fit for investors who need monthly cash flow (ANIX does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on ANIX

Tagged: Healthcare.

Frequently asked questions

Does ANIX pay monthly?

No. ANIX does not currently distribute.

When does ANIX pay a dividend?

ANIX does not currently distribute.

How has ANIX performed?

Total return is -94.0% over the past 42 years. Over the past year its total return — price change plus distributions reinvested — is -24.6%. Its deepest 1-year drawdown was 55.0%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.